These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28978109)

  • 1. Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.
    Feldmann F; Schenk B; Martens S; Vandenabeele P; Fulda S
    Oncotarget; 2017 Sep; 8(40):68208-68220. PubMed ID: 28978109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
    Chromik J; Safferthal C; Serve H; Fulda S
    Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis.
    Rohde K; Kleinesudeik L; Roesler S; Löwe O; Heidler J; Schröder K; Wittig I; Dröse S; Fulda S
    Cell Death Differ; 2017 Jan; 24(1):83-97. PubMed ID: 27834956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
    Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
    Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells.
    Steinwascher S; Nugues AL; Schoeneberger H; Fulda S
    Cancer Lett; 2015 Sep; 366(1):32-43. PubMed ID: 26028172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Safferthal C; Rohde K; Fulda S
    Oncogene; 2017 Mar; 36(11):1487-1502. PubMed ID: 27869161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death.
    Schenk B; Fulda S
    Oncogene; 2015 Nov; 34(47):5796-806. PubMed ID: 25867066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.
    Gerges S; Rohde K; Fulda S
    Cancer Lett; 2016 May; 375(1):127-132. PubMed ID: 26944210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis.
    Laukens B; Jennewein C; Schenk B; Vanlangenakker N; Schier A; Cristofanon S; Zobel K; Deshayes K; Vucic D; Jeremias I; Bertrand MJ; Vandenabeele P; Fulda S
    Neoplasia; 2011 Oct; 13(10):971-9. PubMed ID: 22028622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis.
    Steinhart L; Belz K; Fulda S
    Cell Death Dis; 2013 Sep; 4(9):e802. PubMed ID: 24030154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of FADD and Caspases Affects the Response of T-Cell Leukemia Jurkat Cells to Anti-Cancer Drugs.
    Mrkvová Z; Portešová M; Slaninová I
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel smac mimetic ASTX660 (Tolinapant) and TNF-α synergistically induce necroptosis in bladder cancer cells in vitro upon apoptosis inhibition.
    Wang L; Hu C; Zhao Y; Hu X
    Biochem Biophys Res Commun; 2022 Apr; 602():8-14. PubMed ID: 35247703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury.
    Li JX; Feng JM; Wang Y; Li XH; Chen XX; Su Y; Shen YY; Chen Y; Xiong B; Yang CH; Ding J; Miao ZH
    Cell Death Dis; 2014 Jun; 5(6):e1278. PubMed ID: 24901049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cells.
    Bhatti IA; Abhari BA; Fulda S
    Cancer Lett; 2017 Oct; 405():63-72. PubMed ID: 28716527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomy between Receptor-Interacting Protein 1- and Receptor-Interacting Protein 3-Mediated Necroptosis in Experimental Pancreatitis.
    Wu J; Mulatibieke T; Ni J; Han X; Li B; Zeng Y; Wan R; Wang X; Hu G
    Am J Pathol; 2017 May; 187(5):1035-1048. PubMed ID: 28315674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.
    Brumatti G; Ma C; Lalaoui N; Nguyen NY; Navarro M; Tanzer MC; Richmond J; Ghisi M; Salmon JM; Silke N; Pomilio G; Glaser SP; de Valle E; Gugasyan R; Gurthridge MA; Condon SM; Johnstone RW; Lock R; Salvesen G; Wei A; Vaux DL; Ekert PG; Silke J
    Sci Transl Med; 2016 May; 8(339):339ra69. PubMed ID: 27194727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.
    Martens S; Jeong M; Tonnus W; Feldmann F; Hofmans S; Goossens V; Takahashi N; Bräsen JH; Lee EW; Van der Veken P; Joossens J; Augustyns K; Fulda S; Linkermann A; Song J; Vandenabeele P
    Cell Death Dis; 2017 Jun; 8(6):e2904. PubMed ID: 28661484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necroptosis: Pathway diversity and characteristics.
    de Almagro MC; Vucic D
    Semin Cell Dev Biol; 2015 Mar; 39():56-62. PubMed ID: 25683283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Necroptosis in Human Breast Cancer Drug-Resistant Cells by SMAC Analog LCL161 After Caspase Inhibition Requires RIP3.
    Jin G; Liu Y; Xu P; Jin G
    Pharmazie; 2019 Jun; 74(6):363-368. PubMed ID: 31138375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.